-
Amgen Inc. (AMGN $301.94)
-
AbbVie Inc. (ABBV $197.19)
-
Merck & Company Inc. (MRK $79.86)
-
Pfizer Inc. (PFE $23.53)
Q: Back in July 2020, I purchased ABBV, in a non-registered account, to get exposure to the healthcare sector and to continue to diversify my portfolio outside Canada. Since that time, I am down 16% on ABBV. Knowing 5i recommends ABBV, would you suggest I purchase more ABBV (average down)? Perhaps it would make more sense to sell it, take the tax loss, and purchase another healthcare company based outside of Canada. If your recommendation is to sell, what other healthcare sector companies would you suggest?